Pain Visual analog scale Scale from 0 to 100 (lower is better) · patients with fibromyalgia
1 finding from 1 review
Tender points Tender point score and number of tender points · patients with fibromyalgia
1 finding from 1 review
Multidimensional function FIQ Total Score. Scale 0‐100 (lower scores indicate greater health) · patients with fibromyalgia
1 finding from 1 review
Participant‐reported pain intensity VAS (0‐10, lower score = less pain) · patients with fibromyalgia
1 finding from 1 review
Tender points Tender point score and number of tender points · patients with fibromyalgia
1 finding from 1 review
Physical function · patients with fibromyalgia
1 finding from 1 review
Pain Visual analog scale Scale from 0 to 100 (lower is better) · patients with fibromyalgia
1 finding from 1 review
Tender points Tender point score and number of tender points · patients with fibromyalgia
1 finding from 1 review
Multidimensional function FIQ Total Score. Scale 0‐100 (lower scores indicate greater health) · patients with fibromyalgia
1 finding from 1 review
Intervention not reported
Achievement of low disease state (DAS 28) ‐ not measured · patients with Rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Achievement of low disease state (DAS 28) ‐ not measured · patients with treating rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
DAS (low or remission) · patients with rheumatoid arthritis
1 finding from 1 review
Pain Visual analog scale Scale from 0 to 100 (lower is better) · patients with Shoulder osteoarthritis
1 finding from 1 review
Intervention not reported
Number of patients experiencing any serious adverse event Median follow ‐up: 4 weeks · patients with osteoarthritis
The intervention showed no clear difference in number of patients experiencing any serious adverse event Median… (low certainty).
1 finding from 1 review
Achievement of low disease activity state (DAS 28 less than 3.2, scale 0‐10) · patients with rheumatoid arthritis
Abatacept (2 and 10mg/kg) + DMARDs/biologic probably leads to higher achievement of low disease activity state (DAS 28 less than 3.2,… compared with placebo + DMARDs/biologic (moderate certainty).
1 finding from 1 review
Blood lossTime point: mean 48 hours, range 1 to 13 days. Higher blood loss indicates a worse outcome. · people undergoing total knee replacement
1 finding from 1 review
Pain at post‐operative day 2Scale from 0 (best) to 10 (worst). · people undergoing total knee replacement
1 finding from 1 review
Transfusion rate · people undergoing total knee replacement
It is very uncertain whether any cold therapy changes transfusion rate compared with no cold therapy following total knee replacement (very low certainty).
1 finding from 1 review
Range of motion at discharge Scale from: 0 to 125. · people undergoing total knee replacement
1 finding from 1 review
Function Standardised scale with positive score indicating a better outcome. Scale from 0 (worst) to 100 (best). · people undergoing total knee replacement
1 finding from 1 review